 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
Date |
Open |
High |
Low |
Close |
Volume |
02/10/2025 |
$2.62 |
$2.65 |
$2.53 |
$2.54 |
741.40K | 02/11/2025 |
$2.51 |
$2.53 |
$2.37 |
$2.40 |
1.16M | 02/12/2025 |
$2.41 |
$2.43 |
$2.34 |
$2.40 |
445.60K | 02/13/2025 |
$2.43 |
$2.48 |
$2.37 |
$2.46 |
425.30K | 02/14/2025 |
$2.49 |
$2.59 |
$2.46 |
$2.56 |
395.30K |
 |
MacroGenics, Inc. is a biopharmaceutical company focused on developing and commercializing monoclonal antibody-based therapeutics for the treatment of cancer. It generates its pipeline of product candidates primarily from its suite of antibody-based technology platforms, which have applicability across broad therapeutic domains. It is developing product candidates that target various tumor-associated antigens and immune checkpoint molecules. Its lead pipeline program is vobramitamab duocarmazine (vobra duo), an antibody-drug conjugate (ADC) that targets B7-H3, a molecule in the B7 family of immune regulator proteins that is expressed by several different tumor types. | |
 |

MacroGenics (MGNX) has the following price history information. Looking back at MGNX historical stock prices for the last five trading days, on February 10, 2025, MGNX opened at $2.62, traded as high as $2.65 and as low as $2.53, and closed at $2.54. Trading volume was a total of 741.40K shares. On February 11, 2025, MGNX opened at $2.51, traded as high as $2.53 and as low as $2.37, and closed at $2.40. Trading volume was a total of 1.16M shares. On February 12, 2025, MGNX opened at $2.41, traded as high as $2.43 and as low as $2.34, and closed at $2.40. Trading volume was a total of 445.60K shares. On February 13, 2025, MGNX opened at $2.43, traded as high as $2.48 and as low as $2.37, and closed at $2.46. Trading volume was a total of 425.30K shares. On February 14, 2025, MGNX opened at $2.49, traded as high as $2.59 and as low as $2.46, and closed at $2.56. Trading volume was a total of 395.30K shares.
MGNX Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into MacroGenics shares, starting with a $10,000 purchase of MGNX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/18/2015 |
|
End date: |
02/14/2025 |
|
Start price/share: |
$35.93 |
|
End price/share: |
$2.56 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-92.88% |
|
Average Annual Total Return: |
-23.22% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$712.52 |
|
Years: |
10.00 |
|
|
 |
Date |
Close |
02/10/2025 | $2.54 | 02/11/2025 | $2.40 | 02/12/2025 | $2.40 | 02/13/2025 | $2.46 | 02/14/2025 | $2.56 |
|
 |